JP2016529908A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529908A5 JP2016529908A5 JP2016539674A JP2016539674A JP2016529908A5 JP 2016529908 A5 JP2016529908 A5 JP 2016529908A5 JP 2016539674 A JP2016539674 A JP 2016539674A JP 2016539674 A JP2016539674 A JP 2016539674A JP 2016529908 A5 JP2016529908 A5 JP 2016529908A5
- Authority
- JP
- Japan
- Prior art keywords
- mvp
- solution
- molecule
- binding
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361875729P | 2013-09-10 | 2013-09-10 | |
| US61/875,729 | 2013-09-10 | ||
| PCT/IB2014/064352 WO2015036917A2 (en) | 2013-09-10 | 2014-09-09 | Methods and kits for quantifying the removal of mock virus particles from a purified solution |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019118216A Division JP2019195333A (ja) | 2013-09-10 | 2019-06-26 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016529908A JP2016529908A (ja) | 2016-09-29 |
| JP2016529908A5 true JP2016529908A5 (https=) | 2017-11-16 |
| JP6549126B2 JP6549126B2 (ja) | 2019-07-31 |
Family
ID=52625972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016539674A Active JP6549126B2 (ja) | 2013-09-10 | 2014-09-09 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
| JP2019118216A Withdrawn JP2019195333A (ja) | 2013-09-10 | 2019-06-26 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019118216A Withdrawn JP2019195333A (ja) | 2013-09-10 | 2019-06-26 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US9632087B2 (https=) |
| EP (1) | EP3044339B1 (https=) |
| JP (2) | JP6549126B2 (https=) |
| CN (1) | CN105899684B (https=) |
| AU (3) | AU2014320015B2 (https=) |
| DK (1) | DK3044339T3 (https=) |
| WO (1) | WO2015036917A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9632087B2 (en) | 2013-09-10 | 2017-04-25 | MockV Solutions | Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles |
| EP3882627B1 (en) * | 2018-11-14 | 2024-07-10 | Nissan Chemical Corporation | Container and method for storing, pretreating, and analyzing biomaterial |
| JP7390466B2 (ja) * | 2020-02-28 | 2023-12-01 | 旭化成メディカル株式会社 | ウイルスクリアランス性能の評価方法 |
| US12203914B2 (en) | 2020-11-12 | 2025-01-21 | Sartorius Bioanalytical Instruments, Inc. | Viral clearance evaluation for biological medical product preparation processes |
| CN118465260B (zh) * | 2024-07-09 | 2024-10-15 | 浙江康佰裕生物科技有限公司 | 测定逆转录病毒包膜蛋白elisa方法的建立及应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7966987A (en) * | 1986-09-08 | 1988-04-07 | Applied Biotechnology, Inc. | Empty viral capsid vaccines |
| US5173399A (en) * | 1988-06-10 | 1992-12-22 | Abbott Laboratories | Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests |
| IL92298A (en) * | 1988-11-14 | 2001-04-30 | Us Secretary U S Dept Of Comme | Method for producing isolated empty b19 parvovirus capsids, introducing genes into cells utilizing the same, diagnostic assays for detecting parvovirus infection and an anti-parvovirus vaccine containing said capsids |
| WO1993000103A1 (en) * | 1991-06-21 | 1993-01-07 | The Wistar Institute Of Anatomy And Biology | Chimeric envelope proteins for viral targeting |
| US5814442A (en) * | 1994-06-10 | 1998-09-29 | Georgetown University | Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid |
| EP1268841A4 (en) | 2000-03-27 | 2005-03-09 | Smithkline Beecham Corp | DETECTING VIABLE AGENTS |
| EP1170367A1 (en) * | 2000-06-27 | 2002-01-09 | Bayer Ag | BVDV virus-like particles |
| US20040002058A1 (en) * | 2001-06-21 | 2004-01-01 | Uab Research Foundation | Chimeric capsid proteins and uses thereof |
| US7041444B2 (en) * | 2003-01-14 | 2006-05-09 | Washington University | Murine calicivirus |
| US20050196381A1 (en) * | 2003-09-09 | 2005-09-08 | Xiaobin Lu | Lentivirus vector-based approaches for generating an immune response to HIV in humans |
| EP1973608A1 (en) * | 2005-12-14 | 2008-10-01 | Cytos Biotechnology AG | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| WO2007146197A1 (en) * | 2006-06-09 | 2007-12-21 | Xing-Xiang Li | Methods and reagents for virus isolation and detection |
| WO2008036899A2 (en) * | 2006-09-22 | 2008-03-27 | Amgen Inc. | Methods for removing viral contaminants during protein purification |
| EP2198020B1 (en) * | 2007-09-14 | 2016-04-13 | Institut Pasteur | Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| GB0803068D0 (en) * | 2008-02-20 | 2008-03-26 | Health Prot Agency | Cross-linked biological indicator |
| MX2011004201A (es) * | 2008-10-20 | 2011-05-24 | Abbott Lab | Desactivacion viral durante purificacion de anticuerpos. |
| BR112012025364A2 (pt) * | 2010-04-07 | 2015-09-22 | Novartis Ag | método para geração de partícula semelhante a vírus de parvovírus b19 |
| US9644187B2 (en) * | 2010-04-14 | 2017-05-09 | Emd Millipore Corporation | Methods of producing high titer, high purity virus stocks and methods of use thereof |
| US9632087B2 (en) * | 2013-09-10 | 2017-04-25 | MockV Solutions | Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles |
-
2014
- 2014-09-09 US US14/481,364 patent/US9632087B2/en active Active
- 2014-09-09 JP JP2016539674A patent/JP6549126B2/ja active Active
- 2014-09-09 AU AU2014320015A patent/AU2014320015B2/en active Active
- 2014-09-09 EP EP14843784.1A patent/EP3044339B1/en active Active
- 2014-09-09 WO PCT/IB2014/064352 patent/WO2015036917A2/en not_active Ceased
- 2014-09-09 DK DK14843784.1T patent/DK3044339T3/da active
- 2014-09-09 CN CN201480049583.5A patent/CN105899684B/zh active Active
-
2017
- 2017-03-11 US US15/456,487 patent/US10309963B2/en active Active
-
2019
- 2019-04-17 US US16/386,327 patent/US11754565B2/en active Active
- 2019-06-26 JP JP2019118216A patent/JP2019195333A/ja not_active Withdrawn
-
2021
- 2021-01-27 AU AU2021200484A patent/AU2021200484B2/en active Active
-
2023
- 2023-06-21 US US18/212,606 patent/US12553894B2/en active Active
- 2023-09-12 AU AU2023229501A patent/AU2023229501B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7210518B2 (ja) | 組み換えバクテリオファージを使用する、微生物の迅速検出のための方法及びシステム | |
| Maramorosch et al. | Methods in Virology: Volume V | |
| Anzenbacher et al. | Metabolism of drugs and other xenobiotics | |
| US12006531B2 (en) | Methods and systems for rapid detection of microorganisms using infectious agents | |
| Castello et al. | Comprehensive identification of RNA-binding proteins by RNA interactome capture | |
| JP2016529908A5 (https=) | ||
| CN103764827B (zh) | 可用于分离和／或纯化核酸的试剂 | |
| CN103890176A (zh) | 制备生物材料的方法 | |
| Dobaño-López et al. | Follicular lymphoma microenvironment: an intricate network ready for therapeutic intervention | |
| JP2019195333A (ja) | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット | |
| WO2011103163A2 (en) | Nucleic acid extraction from complex matrices | |
| Liu et al. | Selection of DNA aptamers for subcellular localization of RBSDV P10 protein in the midgut of small brown planthoppers by emulsion PCR-based SELEX | |
| Sousa et al. | A novel method for human hematopoietic stem/progenitor cell isolation from umbilical cord blood based on immunoaffinity aqueous two-phase partitioning | |
| JP2014523405A5 (https=) | ||
| Keck et al. | Comparison of biosafety and diagnostic utility of biosample collection cards | |
| Gasch et al. | Whole genome amplification in genomic analysis of single circulating tumor cells | |
| Jaeschke et al. | Techniques for RNA extraction from cells cultured in starPEG–heparin hydrogels | |
| Shadpour et al. | Enrichment and expansion of cells using antibody‐coated micropallet arrays | |
| Wendlandt et al. | Getting hold of the tobamovirus particle—Why and how? Purification routes over time and a new customizable approach | |
| Mardini et al. | Hidden pitfalls of using onion pollen in molecular research | |
| Fu et al. | Protocol for isolating antigen-specific monoclonal antibodies from immunized mice utilizing the Beacon platform | |
| RU2677336C2 (ru) | Способ получения вирусоподобных частиц папилломавируса человека | |
| Vormittag et al. | Advances in bioprocessing of viral vectors and virus-like particles | |
| Ding et al. | Chromatin immunoprecipitation assay of brain tissues using Percoll gradient-purified nuclei | |
| CN110818773B (zh) | 纯化非人动物羊水中活性物质的方法 |